Pear Bio
Pear Bio is a biotech company focused on patient-centered cancer precision medicine, delivering functional precision medicine tests and therapeutics for hard-to-treat cancers. They create personalized tests by culturing tumor biopsies into 3D immune-microtumors to test various treatment options and predict patient response, matching patients with effective therapies. Additionally, they develop new cancer therapies by analyzing excess tissue with multi-omic approaches to identify novel targets. Their drug discovery platform includes tissue analysis, target identification, validation screens, drug discovery, and patient stratification, emphasizing smarter combination therapies. Pear Bio collaborates with pharmaceutical companies and hospitals to commercialize their precision medicine platform and drug discovery pipeline, positioning themselves as innovators in personalized cancer treatment and drug development.
Pear Bio
Pear Bio is a biotech company focused on patient-centered cancer precision medicine, delivering functional precision medicine tests and therapeutics for hard-to-treat cancers. They create personalized tests by culturing tumor biopsies into 3D immune-microtumors to test various treatment options and predict patient response, matching patients with effective therapies. Additionally, they develop new cancer therapies by analyzing excess tissue with multi-omic approaches to identify novel targets. Their drug discovery platform includes tissue analysis, target identification, validation screens, drug discovery, and patient stratification, emphasizing smarter combination therapies. Pear Bio collaborates with pharmaceutical companies and hospitals to commercialize their precision medicine platform and drug discovery pipeline, positioning themselves as innovators in personalized cancer treatment and drug development.